The Clorox Company (NYSE:CLX – Get Free Report) was the target of some unusual options trading activity on Thursday. Investors acquired 15,500 put options on the stock. This is an increase of approximately 120% compared to the average volume of 7,035 put options.
Clorox Stock Performance
NYSE CLX traded down $0.42 during trading on Thursday, hitting $105.34. 1,783,053 shares of the company’s stock traded hands, compared to its average volume of 2,555,188. The stock has a market capitalization of $12.74 billion, a price-to-earnings ratio of 21.85, a PEG ratio of 3.22 and a beta of 0.54. Clorox has a 12-month low of $84.70 and a 12-month high of $128.90. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The business has a 50 day moving average of $97.50 and a 200-day moving average of $103.34.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The company had revenue of $1.95 billion during the quarter, compared to analysts’ expectations of $1.91 billion. During the same period in the previous year, the business earned $2.87 earnings per share. The firm’s quarterly revenue was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, equities research analysts anticipate that Clorox will post 5.82 earnings per share for the current fiscal year.
Clorox Increases Dividend
Wall Street Analyst Weigh In
A number of research firms have issued reports on CLX. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. Morgan Stanley dropped their price target on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. The Goldman Sachs Group restated a “sell” rating and set a $83.00 price target on shares of Clorox in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft set a $98.00 price objective on shares of Clorox in a research report on Tuesday, August 4th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Clorox from $92.00 to $95.00 and gave the stock an “underweight” rating in a research report on Tuesday, August 4th. Twelve equities research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average price target of $102.40.
View Our Latest Stock Report on Clorox
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Haverford Trust Co raised its position in shares of Clorox by 2.8% during the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after acquiring an additional 84 shares in the last quarter. Field & Main Bank raised its holdings in shares of Clorox by 3.3% during the fourth quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after purchasing an additional 100 shares during the period. Golden State Wealth Management LLC boosted its holdings in shares of Clorox by 28.2% during the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after acquiring an additional 100 shares during the period. Kestra Private Wealth Services LLC boosted its holdings in shares of Clorox by 1.8% during the first quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock valued at $617,000 after acquiring an additional 104 shares during the period. Finally, Johnson Financial Group Inc. grew its position in shares of Clorox by 3.1% during the third quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock worth $451,000 after acquiring an additional 109 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.
About Clorox
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Featured Stories
- Five stocks we like better than Clorox
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
